Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PeriCord (Viscofan)
- Development stage
- Unknown
- Lead developer
- Viscofan
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Epicardial
01
Overview
PeriCord is an advanced therapy medicinal product (ATMP) consisting of a porcine-derived type I collagen membrane (Viscofan Collagen Membrane) seeded with allogeneic adipose-derived mesenchymal stem cells (ADSCs). Developed by Viscofan in collaboration with the Germans Trias i Pujol Health Science Research Institute (IGTP) and the Banc de Sang i Teixits (BST), it is designed for surgical application to the epicardium of patients with chronic ischaemic heart failure. The collagen membrane serves as a bioactive scaffold that ensures the localized retention and survival of the stem cells at the site of myocardial injury. Once implanted, the ADSCs exert therapeutic effects primarily through paracrine signaling, releasing factors that promote angiogenesis, modulate the local immune response, and reduce myocardial fibrosis, with the ultimate goal of improving cardiac function and promoting tissue regeneration.
- Brand names
- PeriCord
- Other names
- epicardial collagen membrane + allogeneic adipose-derived stem cellsViscofan Collagen Membrane seeded with allogeneic adipose-derived mesenchymal stem cells
Beyond the preview
Go deeper on PeriCord (Viscofan).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PeriCord (Viscofan).